MRK
Merck & Co., Inc.
Dividend Growth | |
| Min. Div. Growth Past 7 Yrs. ≥ 15%: 8.9% | |
| Rolling 4-Yrs Div. Growth Past 7 Yrs ≥ 15%: 6.8% | |
| Years of Div. Growth ≥ 15: 54 | |
Income Generation | |
| Current Yield 3.2% ≥ 20-Yrs Treasury Yield 4.7% | |
| Total Dividends ≥ 20-Yrs Treasury Coupons in 5 Yrs | |
Sustainability | |
| Debt-To-Equity 0.46 ≤ 0.45 | |
| Last 12Months Cash Payout 0.68 ≤ 0.6 | |
Profitability | |
| 5-Yr Avg. Return-on-Equity 28.2% ≥ 15% | |
| Last 12Months Return-on-Equity 5.8% ≥ 15% | |
| Last 12Months Net Profit Margin 3.8% ≥ 10% | |
Fair Value | |
| Average 5-Yrs High Yield 3.8% | |
| Current Price $96.3 ≤ High Yield Price $82.1 | |
| Average 5-Yrs Price-to-Earning (P/E) 170.1 | |
| Current Price $96.3 ≤ Average P/E Price $153.1 | |
| Current Price $96.3 ≤ Fair Value $94.0 |
Company Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Dividend
Revenue
Earning
Free Cash Flow